
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
Rana Mhaidly, Fatima Mechta‐Grigoriou
Seminars in Immunology (2020) Vol. 48, pp. 101417-101417
Open Access | Times Cited: 205
Rana Mhaidly, Fatima Mechta‐Grigoriou
Seminars in Immunology (2020) Vol. 48, pp. 101417-101417
Open Access | Times Cited: 205
Showing 1-25 of 205 citing articles:
Clinical and therapeutic relevance of cancer-associated fibroblasts
Yang Chen, Kathleen M. McAndrews, Raghu Kalluri
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 792-804
Open Access | Times Cited: 757
Yang Chen, Kathleen M. McAndrews, Raghu Kalluri
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 792-804
Open Access | Times Cited: 757
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Fanglong Wu, Jin Yang, Junjiang Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 451
Fanglong Wu, Jin Yang, Junjiang Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 451
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
Steven Μ. Albelda
Nature Reviews Clinical Oncology (2023) Vol. 21, Iss. 1, pp. 47-66
Closed Access | Times Cited: 178
Steven Μ. Albelda
Nature Reviews Clinical Oncology (2023) Vol. 21, Iss. 1, pp. 47-66
Closed Access | Times Cited: 178
The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis
Paris Jabeen Asif, Ciro Longobardi, Michael Hahne, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4720-4720
Open Access | Times Cited: 174
Paris Jabeen Asif, Ciro Longobardi, Michael Hahne, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4720-4720
Open Access | Times Cited: 174
Role of cancer‐associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer
Rana Mhaidly, Fatima Mechta‐Grigoriou
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 259-272
Open Access | Times Cited: 161
Rana Mhaidly, Fatima Mechta‐Grigoriou
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 259-272
Open Access | Times Cited: 161
CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion
Gürcan Günaydın
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 142
Gürcan Günaydın
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 142
Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade
Liam Jenkins, Ute Jungwirth, Alexandra Avgustinova, et al.
Cancer Research (2022) Vol. 82, Iss. 16, pp. 2904-2917
Open Access | Times Cited: 141
Liam Jenkins, Ute Jungwirth, Alexandra Avgustinova, et al.
Cancer Research (2022) Vol. 82, Iss. 16, pp. 2904-2917
Open Access | Times Cited: 141
Immune Modulatory Properties of Collagen in Cancer
Anne Mette Askehøj Rømer, Marie‐Louise Thorseth, Daniel H. Madsen
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 138
Anne Mette Askehøj Rømer, Marie‐Louise Thorseth, Daniel H. Madsen
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 138
Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment
Mélanie Desbois, Yulei Wang
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 241-258
Closed Access | Times Cited: 137
Mélanie Desbois, Yulei Wang
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 241-258
Closed Access | Times Cited: 137
Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses
Taghreed Hirz, Shenglin Mei, Hirak Sarkar, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 109
Taghreed Hirz, Shenglin Mei, Hirak Sarkar, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 109
Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance
Rongbin Ge, Zongwei Wang, Liang Cheng
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 95
Rongbin Ge, Zongwei Wang, Liang Cheng
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 95
Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis
Yuqing Ren, Ruizhi Wang, Siyuan Weng, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 57
Yuqing Ren, Ruizhi Wang, Siyuan Weng, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 57
CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
Chunxue Zhang, Yuxiang Fei, Hui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 55
Chunxue Zhang, Yuxiang Fei, Hui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 55
From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts
Ludovica Arpinati, Ruth Scherz‐Shouval
Trends in cancer (2023) Vol. 9, Iss. 5, pp. 421-443
Closed Access | Times Cited: 49
Ludovica Arpinati, Ruth Scherz‐Shouval
Trends in cancer (2023) Vol. 9, Iss. 5, pp. 421-443
Closed Access | Times Cited: 49
PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity
Ruoxin Du, Xiangmei Zhang, Xiyan Lu, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100947-100947
Closed Access | Times Cited: 46
Ruoxin Du, Xiangmei Zhang, Xiyan Lu, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100947-100947
Closed Access | Times Cited: 46
A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer
Mohamed Amgad, James M. Hodge, Maha AT Elsebaie, et al.
Nature Medicine (2023) Vol. 30, Iss. 1, pp. 85-97
Open Access | Times Cited: 42
Mohamed Amgad, James M. Hodge, Maha AT Elsebaie, et al.
Nature Medicine (2023) Vol. 30, Iss. 1, pp. 85-97
Open Access | Times Cited: 42
Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs
Xiaojun Shi, Shiyu Pang, Jiawei Zhou, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 20
Xiaojun Shi, Shiyu Pang, Jiawei Zhou, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 20
Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome
Layla Mathieson, Lilian Koppensteiner, David A. Dorward, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 11, pp. 1758-1769
Open Access | Times Cited: 20
Layla Mathieson, Lilian Koppensteiner, David A. Dorward, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 11, pp. 1758-1769
Open Access | Times Cited: 20
Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy
Zhongsong Zhang, Rong Wang, Long Chen
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 483-503
Open Access | Times Cited: 3
Zhongsong Zhang, Rong Wang, Long Chen
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 483-503
Open Access | Times Cited: 3
Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions
Katrin Pansy, Barbara Uhl, Jelena Krstić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13311-13311
Open Access | Times Cited: 82
Katrin Pansy, Barbara Uhl, Jelena Krstić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13311-13311
Open Access | Times Cited: 82
Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression
Yingying Xing, Guojing Ruan, Haiwei Ni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 67
Yingying Xing, Guojing Ruan, Haiwei Ni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 67
Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging
Agathe Peltier, Romain-David Seban, Irène Buvat, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 262-272
Open Access | Times Cited: 63
Agathe Peltier, Romain-David Seban, Irène Buvat, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 262-272
Open Access | Times Cited: 63
Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling
Pei‐Yu Chen, Wenfei Wei, Hong-Zhen Wu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 61
Pei‐Yu Chen, Wenfei Wei, Hong-Zhen Wu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 61
The Role of Cancer-Associated Fibroblasts in Ovarian Cancer
Mo Zhang, Zhixian Chen, Yan Wang, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2637-2637
Open Access | Times Cited: 50
Mo Zhang, Zhixian Chen, Yan Wang, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2637-2637
Open Access | Times Cited: 50
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 39
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 39